Skip to main content

Jereme Sylvain

Equibles does not estimate personal net worth.

Get an email with a short summary when Dexcom Inc publishes a filing, an earnings call transcript or a press release.

Get DXCM alerts

About Jereme Sylvain

Jereme Sylvain is recorded as COO at Dexcom Inc (DXCM) since September 14, 2026, Chief Accounting Officer at Dexcom Inc (DXCM) since March 9, 2020 and CFO at Dexcom Inc (DXCM). The newest filing on record that lists Jereme Sylvain as CFO at Dexcom Inc (DXCM) is dated April 15, 2026. Dexcom Inc reported in an 8-K filed September 14, 2026 that Jereme Sylvain was appointed EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026. The proxy statement of Dexcom Inc reports total compensation of $7,077,902 for Jereme Sylvain in fiscal 2025, including a base salary of $646,623. Disclosed compensation is on record for 5 fiscal years. Jereme Sylvain has spoken on 22 earnings calls and 1 other investor event across 1 company, most recently for Dexcom Inc on September 9, 2026. Dexcom Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Dexcom Inc includes Jacob Leach (CEO, COO, CTO and Board Member), Jacob S. Leach (CEO, COO and Board Member), Kevin Sayer (CEO, Chairman and Board Member) and 7 others.

“On September 10, 2026, the Board of Directors (the "Board") of DexCom, Inc. ("Dexcom" or the "Company") appointed Jereme Sylvain, the Company's EVP, Chief Financial Officer, to the role of EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.”
Dexcom Inc Form 8-K, filed September 14, 2026 · Read the filing

Jereme Sylvain on recent calls

“Yeah, so look, I think you're assuming that where we are is not in a good position, and there's a lot of continued work. We are in a good position in terms of design and how we're thinking about it.”
CFO, Wells Fargo 21st Annual Healthcare Conference ·
“As a reminder, unless otherwise noted, the financial metrics presented today will be discussed on a non-GAAP basis. Reconciliations to GAAP can be found in today's earnings release as well as the slide deck on our IR website.”
CFO, DexCom, Inc. Second Quarter 2026 Earnings Release Conference Call ·
“As a reminder, unless otherwise noted, the financial measures presented today will be discussed on a non-GAAP basis.”
CFO, Dexcom Inc Q1 FY2026 Earnings Call ·
“As a reminder, unless As otherwise noted, the financial metrics presented today will be discussed on a non-GAAP basis. Reconciliations to GAAP can be found in today's earnings release as well as the slide deck on our IR website.”
CFO, Dexcom Inc Q4 FY2025 Earnings Call ·
“As a reminder, unless otherwise noted, the financial metrics presented today will be discussed on a non-GAAP basis. Reconciliations to GAAP can be found in today's earnings release, as well as the slide deck on our IR website.”
CFO, Dexcom Inc Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Dexcom Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Dexcom Inc (DXCM) $646,623 $7,077,902
2024 Dexcom Inc (DXCM) $609,323 $5,851,112
2023 Dexcom Inc (DXCM) $533,599 $4,254,900
2022 Dexcom Inc (DXCM) $426,288 $3,538,881
2021 Dexcom Inc (DXCM) $379,500 $4,738,880

Recent activity

Show 12 earlier activities